Assessment of atopic dermatitis (AD) severity is essential for therapeutic decision making
and monitoring treatment progress. However, there are a myriad of clinical measurement …

The understanding of the global impact of atopic dermatitis (AD) on the health-related quality
of life (HRQoL) of patients was highly advanced by the development of the Hanifin and …

Background Limited research has been conducted on the measurement properties of the
Recap of atopic eczema (RECAP) questionnaire, particularly in relation to interpretability …

Importance Although several clinician-and patient-reported outcome measures have been
developed for trials in hidradenitis suppurativa (HS), there is currently no consensus on …

Importance Outcome measurement is an essential component of value-based health care
and can aid patient care, quality improvement, and clinical effectiveness evidence …

MATERIALS AND METHODS The patient questionnaire was developed by the authors and
distributed through the Finnish Allergy, Skin and Asthma Federation. Respondents were AD …

Background Several studies have reported that the mountain climate can alleviate asthma,
however, the effect of tropical climate on migratory elderly, especially in people with …

Purpose: Atopic dermatitis (AD) adversely impacts quality of life (QoL). We evaluated the
effect of upadacitinib, an oral selective Janus kinase inhibitor approved for moderate-to …

Background The prevalence of allergic diseases has increased globally, climate and
environment also have important effects on respiratory or allergic diseases. However …

Recap of atopic eczema (RECAP) is a self-reported 7-item questionnaire recommended by
the Harmonising Outcome Measures in Eczema initiative to measure eczema control. As …